BR112022010153A2 - Peptídeos, ácido nucleico, polipeptídeo, composição, complexo bioluminescente, métodos, dipeptídeo, sistema e kit - Google Patents
Peptídeos, ácido nucleico, polipeptídeo, composição, complexo bioluminescente, métodos, dipeptídeo, sistema e kitInfo
- Publication number
- BR112022010153A2 BR112022010153A2 BR112022010153A BR112022010153A BR112022010153A2 BR 112022010153 A2 BR112022010153 A2 BR 112022010153A2 BR 112022010153 A BR112022010153 A BR 112022010153A BR 112022010153 A BR112022010153 A BR 112022010153A BR 112022010153 A2 BR112022010153 A2 BR 112022010153A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- polypeptide
- dipeptide
- peptides
- kit
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 3
- 108010016626 Dipeptides Proteins 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 230000003993 interaction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
- G01N21/763—Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
- C12Y113/12005—Renilla-luciferin 2-monooxygenase (1.13.12.5), i.e. renilla-luciferase
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Plasma & Fusion (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962941255P | 2019-11-27 | 2019-11-27 | |
| PCT/US2020/062499 WO2021108765A1 (en) | 2019-11-27 | 2020-11-27 | Multipartite luciferase peptides and polypeptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022010153A2 true BR112022010153A2 (pt) | 2022-08-09 |
Family
ID=74106118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022010153A BR112022010153A2 (pt) | 2019-11-27 | 2020-11-27 | Peptídeos, ácido nucleico, polipeptídeo, composição, complexo bioluminescente, métodos, dipeptídeo, sistema e kit |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12241839B2 (https=) |
| EP (1) | EP4065699A1 (https=) |
| JP (2) | JP7713448B2 (https=) |
| KR (1) | KR20220121816A (https=) |
| CN (1) | CN115427556A (https=) |
| AU (1) | AU2020392245A1 (https=) |
| BR (1) | BR112022010153A2 (https=) |
| CA (1) | CA3158729A1 (https=) |
| IL (1) | IL293204A (https=) |
| WO (1) | WO2021108765A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3395803A1 (en) | 2017-04-28 | 2018-10-31 | Institut Pasteur | Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins |
| EP3941195A4 (en) | 2019-03-20 | 2023-03-22 | Promega Corporation | PHOTOAFFINITY PROBES |
| US20240003881A1 (en) * | 2020-12-04 | 2024-01-04 | The Governing Council Of The University Of Toronto | System and method for rapid and sensitive detection of anti-pathogen antibodies |
| EP4337646A4 (en) | 2021-05-13 | 2025-05-21 | Promega Corporation | BIOLUMINESCENT DETECTION OF DNA SYNTHESIS |
| WO2023039535A1 (en) * | 2021-09-09 | 2023-03-16 | Trustees Of Tufts College | Outer membrane vesicle (omv)-based vaccines against sudden acute respiratory syndrome coronavirus 2 (sars-cov-2) spike protein |
| KR20240154535A (ko) * | 2022-01-17 | 2024-10-25 | 유니버시티 오브 워싱턴 | 새롭게 설계된 루시퍼라제 |
| WO2023215497A1 (en) | 2022-05-04 | 2023-11-09 | Promega Corporation | Photoactivatable compounds and uses thereof |
| GB2619059A (en) * | 2022-05-26 | 2023-11-29 | Univ Leeds Innovations Ltd | Split reporter complex |
| AU2024265176A1 (en) * | 2023-05-04 | 2025-12-11 | Promega Corporation | Complementation-based tags and reporters for dual-modality labeling |
| WO2025064581A1 (en) * | 2023-09-18 | 2025-03-27 | The Brigham And Women’S Hospital, Inc. | Biosensor platform for the rapid detection of analytes |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0281604B1 (en) | 1986-09-02 | 1993-03-31 | Enzon Labs Inc. | Single polypeptide chain binding molecules |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5260203A (en) | 1986-09-02 | 1993-11-09 | Enzon, Inc. | Single polypeptide chain binding molecules |
| US5914095A (en) | 1989-04-07 | 1999-06-22 | Salutar, Inc. | Polychelants containg amide bonds |
| US5368484A (en) | 1992-05-22 | 1994-11-29 | Atari Games Corp. | Vehicle simulator with realistic operating feedback |
| US5756688A (en) | 1992-10-14 | 1998-05-26 | Sterling Winthrop Inc. | MR imaging compositions and methods |
| WO1994009056A1 (en) | 1992-10-14 | 1994-04-28 | Sterling Winthrop Inc. | Chelating polymers |
| GB9503969D0 (en) | 1995-02-28 | 1995-04-19 | Sams Bernard | Incrementing mechanism |
| US7268229B2 (en) | 2001-11-02 | 2007-09-11 | Promega Corporation | Compounds to co-localize luminophores with luminescent proteins |
| US20080248511A1 (en) | 2007-03-26 | 2008-10-09 | Promega Corporation | Methods to quench light from optical reactions |
| LT3409764T (lt) | 2009-05-01 | 2020-06-10 | Promega Corporation | Sintetinės oplophorus liuciferazės su sustiprinta šviesos išeiga |
| TW201105646A (en) | 2009-05-28 | 2011-02-16 | Solvay Fluor Gmbh | Process for the preparation of 4-fluoro-4-R-5-R'-1,3-dioxolane-2-ones |
| BR112013010487B1 (pt) | 2010-11-02 | 2021-02-02 | Promega Corporation | compostos de coelenterazina, kit compreendendo ditos compostos e método para detectar luminescência em uma amostra in vitro |
| WO2012061477A1 (en) | 2010-11-02 | 2012-05-10 | Promega Corporation | Coelenterazine derivatives and methods of using same |
| EP2782916B1 (en) | 2011-11-21 | 2018-02-28 | Promega Corporation | Carboxy x rhodamine analogs |
| WO2013177255A2 (en) | 2012-05-24 | 2013-11-28 | Connecticut College | Chimeric luciferases |
| AU2013266968B2 (en) | 2012-05-25 | 2017-06-29 | Emmanuelle CHARPENTIER | Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription |
| US20140099654A1 (en) | 2012-09-26 | 2014-04-10 | Promega Corporation | Real-time monitoring |
| US8697359B1 (en) | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| SG11201507306VA (en) | 2013-03-15 | 2015-10-29 | Promega Corp | Activation of bioluminescence by structural complementation |
| US11365402B2 (en) | 2014-09-12 | 2022-06-21 | Promega Corporation | Internal protein tags |
| EP3254113B1 (en) | 2015-02-05 | 2024-10-09 | Promega Corporation | Luciferase-based thermal shift assays |
| US9908918B2 (en) | 2015-06-30 | 2018-03-06 | The Board Of Trustees Of The Leland Stanford Junior University | Cyan-excitable orange-red fluorescent proteins and bioluminescent resonance energy transfer systems |
| EP3416968B1 (en) | 2016-02-15 | 2022-07-27 | Promega Corporation | Coelenterazine analogues |
| US10634680B2 (en) | 2016-04-26 | 2020-04-28 | University Of Utah Research Foundation | Target-binding activated split reporter systems for analyte detection and related components and methods |
| JP7212612B2 (ja) | 2016-07-28 | 2023-01-25 | プロメガ コーポレイション | セレンテラジン類縁体 |
| PL3759233T4 (pl) | 2018-02-26 | 2022-10-10 | Technische Universiteit Eindhoven | Bioczujnik bioluminescencyjny do wykrywania i oznaczania ilościowego biocząsteczek |
| EP3807419A4 (en) | 2018-06-12 | 2022-09-07 | Promega Corporation | MULTIPLE LUCIFERASE |
| US10962538B2 (en) * | 2018-06-14 | 2021-03-30 | The Trustees Of Columbia University In The City Of New York | Assays using arrestin recruitment and unmodified receptors |
| BR112021020354A2 (pt) | 2019-04-10 | 2021-12-14 | Promega Corp | Composições e métodos para detecção de analito com o uso de bioluminescência |
-
2020
- 2020-11-27 KR KR1020227021856A patent/KR20220121816A/ko active Pending
- 2020-11-27 EP EP20834006.7A patent/EP4065699A1/en active Pending
- 2020-11-27 CN CN202080095195.6A patent/CN115427556A/zh active Pending
- 2020-11-27 JP JP2022531486A patent/JP7713448B2/ja active Active
- 2020-11-27 CA CA3158729A patent/CA3158729A1/en active Pending
- 2020-11-27 WO PCT/US2020/062499 patent/WO2021108765A1/en not_active Ceased
- 2020-11-27 US US17/105,925 patent/US12241839B2/en active Active
- 2020-11-27 AU AU2020392245A patent/AU2020392245A1/en active Pending
- 2020-11-27 IL IL293204A patent/IL293204A/en unknown
- 2020-11-27 BR BR112022010153A patent/BR112022010153A2/pt unknown
-
2025
- 2025-02-10 US US19/050,016 patent/US20250297961A1/en active Pending
- 2025-07-14 JP JP2025118267A patent/JP2025162556A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3158729A1 (en) | 2021-06-03 |
| CN115427556A (zh) | 2022-12-02 |
| KR20220121816A (ko) | 2022-09-01 |
| IL293204A (en) | 2022-07-01 |
| US12241839B2 (en) | 2025-03-04 |
| JP7713448B2 (ja) | 2025-07-25 |
| EP4065699A1 (en) | 2022-10-05 |
| US20250297961A1 (en) | 2025-09-25 |
| WO2021108765A1 (en) | 2021-06-03 |
| JP2023503653A (ja) | 2023-01-31 |
| US20210262941A1 (en) | 2021-08-26 |
| JP2025162556A (ja) | 2025-10-27 |
| AU2020392245A1 (en) | 2022-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022010153A2 (pt) | Peptídeos, ácido nucleico, polipeptídeo, composição, complexo bioluminescente, métodos, dipeptídeo, sistema e kit | |
| WO2019191633A3 (en) | Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof | |
| BR112018000660A2 (pt) | peptídeos anti-inflamatórios e seu uso | |
| PE20201183A1 (es) | Proteinas trispecificas y metodos de uso | |
| MX2020004578A (es) | Composiciones de casz y metodos de uso. | |
| EA202190906A1 (ru) | Рекомбинантное получение препаратов пептидов коллагена и их применение | |
| BR112016015512A2 (pt) | proteínas quiméricas de fator viii e suas utilizações | |
| EA201991168A1 (ru) | Белок, связывающий простатический специфический мембранный антиген | |
| WO2021236716A3 (en) | Methods, systems and kits for polypeptide processing and analysis | |
| AU2017263237A1 (en) | GDF15 fusion proteins and uses thereof | |
| BRPI0620806B8 (pt) | complexo e composição compreendendo um peptídeo e uma molécula carga, e uso da referida composição | |
| CY1113117T1 (el) | Ηlα-α*3303-περιορισμενο wt1 πεπτιδιο και φαρμακευτικη συνθεση η οποια περιλαμβανει αυτο το ιδιο | |
| MX2019003298A (es) | Proteinas de union recombinantes y sus usos. | |
| BR112017015567A2 (pt) | proteína gl de citomegalovírus recombinante ou fragmento de formação de complexo da mesma, complexo de citomegalovírus, ácido nucleico isolado, célula hospedeira, e, composição imunogênica | |
| MX2018005063A (es) | Polipéptidos condicionalmente activos. | |
| SI3079715T1 (en) | A mixture of peptides | |
| BR112022008075A2 (pt) | Métodos de seqüênciamento de proteínas de célula única e de ácido nucleico | |
| CL2017000200A1 (es) | Célula huésped mejorada para producir proteinas | |
| HRP20150664T1 (hr) | Antikancerogeni fuzijski protein | |
| MX2020000018A (es) | Potencializacion de componentes sanguineos de actividad anti-bacteriana de proteina litica y metodos y usos de estos. | |
| CL2017003097A1 (es) | Composiciones y métodos para el tratamiento de la enfermedad celiaca | |
| BR112018013246A2 (pt) | rótulo de peptídeo e proteína rotulada incluindo o mesmo | |
| EA201892325A1 (ru) | Композиции и способы детектирования белков клетки-хозяина | |
| BR112018073669A2 (pt) | proteína de fusão, composição de uma primeira proteína e uma segunda proteína, complexo de uma primeira proteína e uma segunda proteína, polinucleotídeos que codificam uma proteína de fusão, vetor contendo o polinucleotídeo, célula hospedeira contendo o polinucleotídeo, uso de uma proteína de fusão, composição farmacêutica, e composição farmacêutica para uso | |
| PE20161406A1 (es) | Proteinas de fusion tatk-cdkl5, composiciones, formulaciones y uso de estas |